Accéder au contenu
Merck

A practical synthesis of 5-lipoxygenase inhibitor MK-0633.

The Journal of organic chemistry (2010-05-22)
Francis Gosselin, Robert A Britton, Ian W Davies, Sarah J Dolman, Danny Gauvreau, R Scott Hoerrner, Gregory Hughes, Jacob Janey, Stephen Lau, Carmela Molinaro, Christian Nadeau, Paul D O'Shea, Michael Palucki, Rick Sidler
RÉSUMÉ

Practical, chromatography-free syntheses of 5-lipoxygenase inhibitor MK-0633 p-toluenesulfonate (1) are described. The first route used an asymmetric zincate addition to ethyl 2,2,2-trifluoropyruvate followed by 1,3,4-oxadiazole formation and reductive amination as key steps. An improved second route features an inexpensive diastereomeric salt resolution of vinyl hydroxy-acid 22 followed by a robust end-game featuring a through-process hydrazide acylation/1,3,4-oxadiazole ring closure/salt formation sequence to afford MK-0633 p-toluenesulfonate (1).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sodium p-toluenesulfonate, 95%
Sigma-Aldrich
p-Toluenesulfonic acid monohydrate, ACS reagent, ≥98.5%
Sigma-Aldrich
Silver p-toluenesulfonate, ≥99%
Sigma-Aldrich
p-Toluenesulfonic acid monohydrate, ReagentPlus®, ≥98%